Dashboard
Manage Tickers

IBIO iBio, Inc.

NYSE ibioinc.com


$ 0.85 $ 0.00 (0.53 %)    

Friday, 17-Oct-2025 19:12:44 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.85
$ 0.86
$ 0.81 x 243
$ 0.91 x 500
$ 0.84 - $ 0.91
$ 0.56 - $ 6.89
738,491
na
16.71M
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-05-2025 06-30-2025 10-K
2 05-02-2025 03-31-2025 10-Q
3 02-10-2025 12-31-2024 10-Q
4 11-12-2024 09-30-2024 10-Q
5 09-20-2024 06-30-2024 10-K
6 05-13-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-Q
8 11-14-2023 09-30-2023 10-Q
9 09-27-2023 06-30-2023 10-K
10 05-15-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-Q
12 11-14-2022 09-30-2022 10-Q
13 10-11-2022 06-30-2022 10-K
14 05-12-2022 03-31-2022 10-Q
15 02-14-2022 12-31-2021 10-Q
16 11-15-2021 09-30-2021 10-Q
17 09-28-2021 06-30-2021 10-K
18 05-17-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-Q
20 11-16-2020 09-30-2020 10-Q
21 10-13-2020 06-30-2020 10-K
22 05-15-2020 03-31-2020 10-Q
23 02-14-2020 12-31-2019 10-Q
24 11-14-2019 09-30-2019 10-Q
25 08-26-2019 06-30-2019 10-K
26 05-10-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-Q
28 11-13-2018 09-30-2018 10-Q
29 09-18-2018 06-30-2018 10-K
30 05-11-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-Q
32 11-09-2017 09-30-2017 10-Q
33 09-15-2017 06-30-2017 10-K
34 05-15-2017 03-31-2017 10-Q
35 02-21-2017 12-31-2016 10-Q
36 11-18-2016 09-30-2016 10-Q
37 10-13-2016 06-30-2016 10-K
38 05-23-2016 03-31-2016 10-Q
39 02-22-2016 12-31-2015 10-Q
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-booz-allen-hamilton-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday
This Booz Allen Hamilton Analyst Is No Lon...
10/17/2025 16:23:02

this-kontoor-brands-analyst-begins-coverage-on-a-bullish-note-here-are-top-4-initiations-for-friday
This Kontoor Brands Analyst Begins Coverag...
10/17/2025 12:20:05

leerink-partners-initiates-coverage-on-ibio-with-outperform-rating-announces-price-target-of-2
Leerink Partners Initiates Coverage On iBi...
10/17/2025 11:47:24

Leerink Partners analyst Roanna Ruiz initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price T...

ibio-says-revenues-for-the-fiscal-year-ended-june-30-2025-were-approximately-04m-an-increase-of-02m-over-fiscal-year-2024
iBio Says Revenues For The Fiscal Year End...
09/05/2025 11:34:57

why-serina-therapeutics-shares-are-trading-higher-by-over-25-here-are-20-stocks-moving-premarket
Why Serina Therapeutics Shares Are Trading...
08/26/2025 09:52:07

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 12:08:33

ibio-prices-public-offering-for-gross-proceeds-of-50m
iBio Prices Public Offering For Gross Proc...
08/19/2025 12:05:30

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

ibio-announces-proposed-public-offering-size-not-disclosed
iBio Announces Proposed Public Offering; S...
08/18/2025 20:01:53

chardan-capital-maintains-buy-on-ibio-maintains-5-price-target
Chardan Capital Maintains Buy on iBio, Mai...
06/25/2025 12:34:51

Chardan Capital analyst Keay Nakae maintains iBio (NASDAQ:IBIO) with a Buy and maintains $5 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 12:08:47

ibio-announces-preclinical-data-in-which-an-engineered-amylin-receptor-agonist-antibody-reduced-acute-food-intake-in-a-mouse-model-of-obesity-by-60-equivalent-to-the-reduction-in-food-intake-from-a-clinically-advanced-dual-amylin-and-calcitonin-receptor-agonist-peptide-67
iBio Announces Preclinical Data In Which A...
06/24/2025 11:03:12

Lead amylin receptor agonist engineered antibody significantly reduced acute food intake in a mouse model of obesity, comparabl...

why-nektar-therapeutics-shares-are-trading-higher-by-over-30-here-are-20-stocks-moving-premarket
Why Nektar Therapeutics Shares Are Trading...
06/24/2025 10:38:26

us-stocks-likely-to-open-higher-after-trump-announces-iran-israel-ceasefire-fedex-td-synnex-in-focus-ahead-of-earnings
US Stocks Likely To Open Higher After Trum...
06/24/2025 09:46:59

U.S. futures were trading higher on Tuesday after a positive day of trade on Monday. Futures of major benchmark indices were tr...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/23/2025 21:06:48

ibio-announces-it-will-host--conference-call-on-tuesday-june-24-at-830-am-est-to-review-its-latest-advances-in-obesity-and-cardiometabolic-disease-treatments-and-announce-a-third-target-in-the-astralbio-collaboration-in-addition-to-myostatin-and-activin-e
ibio Announces It Will Host Conference Ca...
06/23/2025 20:17:49

Review of promising Myostatin and Activin E antibody dataiBio to announce 3rd target in Astral Bio CollaborationConference call...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 21:06:23

ibio-initiates-non-human-primate-study-for-its-activin-e-engineered-antibody-candidate-now-named-ibio-610-this-preclinical-study-will-evaluate-the-pharmacokinetics-and-early-signs-of-efficacy-of-ibio-610-in-obese-and-elderly-nhps-including-its-impact-on-fat-and-body-composition
iBio Initiates Non-human Primate Study For...
06/16/2025 11:06:49

iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibodyNew study aims to evaluate the half-l...

chardan-capital-maintains-buy-on-ibio-maintains-5-price-target
Chardan Capital Maintains Buy on iBio, Mai...
05/05/2025 12:25:05

Chardan Capital analyst Keay Nakae maintains iBio (NASDAQ:IBIO) with a Buy and maintains $5 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
05/05/2025 12:07:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION